For today’s #ThrowbackThursday we have the PEACE trial! Check out PharmD candidate, Sado Essa’s awesome review of the PEACE trial and how it compares to HOPE and EUROPA #CardioTwitter

Don't forget to join us TOMORROW for a webinar highlighting key trials from ACC/ISHLT!

When: May 7th from 3-4 PM EST

Trials to be discussed by some of our excellent members:

EMPACT-MI
DANGER-SHOCK
REDUCE-AMI
Ultimate-DAPT

Please see communities page for zoom link!

For #ThrowbackThursday let’s review the SIGNIFY Trial! SIGNIFY failed to show a benefit of ivabradine in patients with stable CAD without clinical heart failure and ⬆️ rates of symptomatic bradycardia. Today’s infographic was prepared by current cards PGY2 resident Maria Ruiz!

Please join us next week for a webinar highlighting key trials from ACC/ISHLT!

When: May 7th from 3-4 PM EST

Trials to be discussed by some of our excellent members:

EMPACT-MI
DANGER-SHOCK
REDUCE-AMI
Ultimate-DAPT

Please see communities page for zoom link!

It’s #WhatsNewWednesday ! See new ESC statement on peripartum heart failure...with considerations from pre-conception to postpartum.

Check it out 👇

onlinelibrary.wiley.com/doi/10.1002/ej…

It's time for another #TeachingTuesday !! Check out this amazing infographic on Antithrombotic Management After TAVR created by the University of Maryland's PGY-2 Cardiology Pharmacy Resident, Tiffany Gardner, PharmD! 🫀

Please join us for a webinar highlighting key trials from ACC/ISHLT!

When: May 7th from 3-4 PM EST

Trials to be discussed by some of our excellent members:

EMPACT-MI
DANGER-SHOCK
REDUCE-AMI
Ultimate-DAPT

Please see communities page for zoom link!

🚨 Attention all students 🚨

Don't miss our #NAPLEXTwitterTakeover series beginning Tuesday, May 7th!

Our next #TeachingTuesday is brought to you by the University of Maryland's PGY-2 Cardiology Pharmacy Resident, Tiffany Gardner, PharmD! Be sure to check out her infographic on Antithrombotic Management after TAVR!

It's #ThrowbackThursday as we look at the ALBATROSS trial. This trial found that the use of MRA did not reduce the incidence of death or cardiovascular events in patients with an acute MI, independent of ejection fraction. Graphic by Feifei Jia!

jacc.org/doi/10.1016/j.…

Happy #WhatsNewWednesday !

Recently published REDUCE-AMI found long-term beta blockers after MI with preserved EF did not decrease mortality or new MI ➡️ potentially questioning modern post-MI care!

nejm.org/doi/full/10.10…

Have you read the 2023 ACC/AHA/ACCP/HRS #AFib Guidelines? We have Dr. Monaz Engineer, PGY2 Cardiology Pharmacy Resident UChicago Medicine Pharmacy Residency Programs, here to break down rate vs rhythm control. Check out the last image for a great reference of patient factors to consider!
#CardioEd